FDA Approves Takeda’s EoE Therapy EOHILIA
FDA approves Takeda's EOHILIA as first-line treatment for Eosinophilic Esophagitis. Groundbreaking oral therapy offers hope for improved quality of life.
- Latest
- Trending
FDA approves Takeda's EOHILIA as first-line treatment for Eosinophilic Esophagitis. Groundbreaking oral therapy offers hope for improved quality of life.
Assure Holdings announces merger agreement with Danam Health, creating a Nasdaq-listed entity in pharmaceutical and healthcare sectors. The merger is ...
UBS upgrades GE HealthCare Technologies to Neutral, raises price target to $88. Positive outlook for company's margin improvement and revenue ...
Biopharmaceutical company Atossa Genetics receives Buy rating from H.C. Wainwright, with a new price target of $4.00. The company's promising ...
TD Cowen increases price target for HCA Holdings, expects strong performance & market share growth. Positive outlook for the healthcare ...
Sharp HealthCare is leading the way in bringing Apple's Vision Pro VR headset into healthcare. The high-resolution screens and advanced ...
The Australian stock market closed lower, with the S&P/ASX 200 down 0.39%. Technology, consumer discretionary, and healthcare sectors dragged down ...
Reflecting on the evolution of virtual reality, this article explores how the technology has progressed and the potential it holds ...
A Fed survey reveals disparities in stock investments among racial groups, with white households leading. Black-owned businesses faced challenges during ...
Wall Street had a positive week, closing above 5,000 for the first time ever. Next week will bring key macroeconomic ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.